Articles

Clinical Management of Non-alcoholic Steatohepatitis

Published:

22 December 2023

Citation:

European Cardiology Review 2023;18:e64.

Gaps in Modern Heart Failure and Chronic Kidney Disease Research

Published:

23 August 2023

Citation:

European Cardiology Review 2023;18:e51.

Cardiometabolic Risk Factors and COVID-19 in the Asia-Pacific Region

Published:

23 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e22.

Timing of SGLT2 Inhibitors in Heart Failure

Published:

07 June 2023

Citation:

European Cardiology Review 2023;18:e41.

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e23.

The Predictive Value of NT-proBNP across Glomerular Filtration Rate Subsets in Heart Failure Treated Patients

Published:

25 April 2023

Citation:

European Cardiology Review 2023;18:e18.

Epicardial Fat in HFpEF: Correlation or Causation?

Published:

15 April 2023

Citation:

Cardiac Failure Review 2023;9:e06.

Management of HF in Patients with CKD

Published:

26 July 2022

Citation:

European Cardiology Review 2022;17:e17.

SGLT2i in HFpEF

Published:

08 July 2022

Citation:

Cardiac Failure Review 2022;8:e26.

APSC Consensus on OSA in CVD Patients

Published:

20 June 2022

Citation:

European Cardiology Review 2022;17:e16.